Filip Poelaert (@fpoelaert) 's Twitter Profile
Filip Poelaert

@fpoelaert

MD PhD FEBU -
Urologist @ZAS_Ziekenhuis

ID: 732576898484711424

calendar_today17-05-2016 14:21:58

190 Tweet

140 Followers

97 Following

European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

NEW: The EAU Guidelines Bot The right answers, seconds away Ask personalised treatment questions and receive instant answers based on the EAU Guidelines. Available in each topic section of the EAU Guidelines. Try it today via the Guidelines page: uroweb.org/guidelines

European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

🚫 To prevent urethral strictures: ✅ Avoid unnecessary catheterisation 👩‍⚕️ Train staff on proper technique 🔁 Use ≤18 Fr catheters for drainage ❌ Avoid non-coated latex catheters Prevention starts with small, evidence-based steps. #UrethralStrictures #EAUGuidelines

Steffi Yuen (@steffiyuen) 's Twitter Profile Photo

🎉Our work was published at European Urology today! 🪭Randomized noninferiority trial: Flexible and Navigable Suction Ureteral Access Sheath flexible ureteroscopy #FANS #fURS vs #miniPCNL in 2-3cm renal stone 🔗 doi.org/10.1016/j.euru… #GuohuaZeng #WeiZhu #fansofFANS #UroSoMe

🎉Our work was published at European Urology today! 
🪭Randomized noninferiority trial: Flexible and Navigable Suction Ureteral Access Sheath flexible ureteroscopy #FANS #fURS vs #miniPCNL in 2-3cm renal stone 
🔗 doi.org/10.1016/j.euru…
#GuohuaZeng #WeiZhu #fansofFANS #UroSoMe
European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

🧾 Cheat Sheet on Follow-up for NMIBC 🔹 Risk-based surveillance 🔹 Lifelong follow-up for high-risk patients 🔹 Role of cytology & markers 🔍 No substitute for cystoscopy Download Cheat Sheet: uroweb.org/guidelines/non… #BladderCancer #NMIBC #EAUguidelines

🧾 Cheat Sheet on Follow-up for NMIBC

🔹 Risk-based surveillance
🔹 Lifelong follow-up for high-risk patients
🔹 Role of cytology & markers
🔍 No substitute for cystoscopy

Download Cheat Sheet:
uroweb.org/guidelines/non…

#BladderCancer #NMIBC #EAUguidelines
European Urology (@euplatinum) 's Twitter Profile Photo

📢 New in European Urology Amar Kishan et al: 🎯 MRI-guided SBRT for prostate cancer significantly reduces late GU and GI toxicity vs CT-guided SBRT at 2 years! 🔬 In the MIRAGE RCT, MRI guidance with tighter margins (2 mm) halved GU toxicity (27% vs 51%) and markedly reduced

📢 New in European Urology <a href="/AmarUKishan/">Amar Kishan</a> et al:

🎯 MRI-guided SBRT for prostate cancer significantly reduces late GU and GI toxicity vs CT-guided SBRT at 2 years!

🔬 In the MIRAGE RCT, MRI guidance with tighter margins (2 mm) halved GU toxicity (27% vs 51%) and markedly reduced
European Urology (@euplatinum) 's Twitter Profile Photo

📘 Just published in European Urology: 🔄 The 2025 EAU Guidelines on UTUC are here! 🧬 Major updates include: • Revised risk stratification framework • New recommendations for kidney-sparing approaches in low-risk UTUC • Clarified indications for perioperative chemotherapy &

📘 Just published in European Urology:

🔄 The 2025 EAU Guidelines on UTUC are here!

🧬 Major updates include:
• Revised risk stratification framework
• New recommendations for kidney-sparing approaches in low-risk UTUC
• Clarified indications for perioperative chemotherapy &amp;
Nikolas De Meurechy (@ndemeurechy) 's Twitter Profile Photo

Beste VRT NWS VTM NIEUWS Medi-Sfeer De Specialist en N-VA cd&v omdat jullie blijkbaar nog steeds niet goed begrijpen wat de kaderwet juist omvat, heb ik het even zeer summier samengevat. En dan heb ik nog niet alles beschreven.

Beste <a href="/vrtnws/">VRT NWS</a> <a href="/VTMNIEUWS/">VTM NIEUWS</a> <a href="/MediSfeer/">Medi-Sfeer</a> <a href="/specialistkrant/">De Specialist</a> en <a href="/de_NVA/">N-VA</a> <a href="/cdenv/">cd&v</a> omdat jullie blijkbaar nog steeds niet goed begrijpen wat de kaderwet juist omvat, heb ik het even zeer summier samengevat. En dan heb ik nog niet alles beschreven.
Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo

Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data sciencedirect.com/science/articl… This systematic review and meta-analysis by the DADSPORT Collaboration

Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data

sciencedirect.com/science/articl…

This systematic review and meta-analysis by the DADSPORT Collaboration
The Lancet Oncology (@thelancetoncol) 's Twitter Profile Photo

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a phase 3 thelancet.com/journals/lanon… Authors: Alison Tree 💙, Nicholas van As, & Prof Emma Hall The Royal Marsden Cancer Charity, Accuray, The ICR

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a phase 3  thelancet.com/journals/lanon…

Authors: <a href="/alison_tree/">Alison Tree 💙</a>, <a href="/nickva1/">Nicholas van As</a>, &amp; <a href="/EmmaHall71/">Prof Emma Hall</a>

<a href="/royalmarsden/">The Royal Marsden Cancer Charity</a>, <a href="/Accuray/">Accuray</a>, <a href="/ICR_London/">The ICR</a>
UroToday.com (@urotoday) 's Twitter Profile Photo

Can we kill the bone scan? Daniel E Spratt Case Comp Cancer Ctr presents on bone scan obsolescence in #ProstateCancer imaging. Dr. Spratt demonstrates that they fail to detect cancer with sufficient sensitivity compared to PSMA PET, having no role in diagnosis or staging across disease states.

Can we kill the bone scan? <a href="/DrSpratticus/">Daniel E Spratt</a> <a href="/caseccc/">Case Comp Cancer Ctr</a> presents on bone scan obsolescence in #ProstateCancer imaging. Dr. Spratt demonstrates that they fail to detect cancer with sufficient sensitivity compared to PSMA PET, having no role in diagnosis or staging across disease states.
European Urology (@euplatinum) 's Twitter Profile Photo

🆕 Check this out! The 2025 #EAUGuidelines on #Urolithiasis are now published in European Urology 📘 🔍 Covering: ✅ State-of-the-art imaging (US, low-dose CT) ✅ MET, ESWL, URS, PCNL ✅ Genetic testing in high-risk patients ✅ Personalized treatment pathways ✅ Practical

🆕 Check this out! The 2025 #EAUGuidelines on #Urolithiasis are now published in European Urology 📘

🔍 Covering:
✅ State-of-the-art imaging (US, low-dose CT)
✅ MET, ESWL, URS, PCNL
✅ Genetic testing in high-risk patients
✅ Personalized treatment pathways
✅ Practical
Jim Hu (@jimhumd) 's Twitter Profile Photo

👀 ⭐️Gal Wald NewYork-Presbyterian Keith Kowalczyk, MD Georgetown University Urology 10th European Urology journals Surgery in Motion. Largest comparison of Hood, Retzius vs Std Robotic RP: Retzius>Hood>Std continence recovery, but ⬆️ Retzius + SMs sciencedirect.com/science/articl…

👀 ⭐️<a href="/WaldoGMed/">Gal Wald</a> <a href="/nyphospital/">NewYork-Presbyterian</a> <a href="/KeithKow/">Keith Kowalczyk, MD</a> <a href="/GUUrology/">Georgetown University Urology</a> 10th <a href="/EUplatinum/">European Urology</a> journals Surgery in Motion. Largest comparison of Hood, Retzius vs Std Robotic RP: Retzius&gt;Hood&gt;Std continence recovery, but ⬆️ Retzius + SMs sciencedirect.com/science/articl…
Ashish M. Kamat, MD, MBBS (@urodocash) 's Twitter Profile Photo

J&J receives U.S. FDA Priority Review for TAR-200 in high-risk NMIBC Phase 2b SunRISe-1 study #AUA25 ✅82.4 % CR rate ☑️ 52.9 % cancer-free at least one year after CR jnj.com/media-center/p…

J&amp;J receives <a href="/US_FDA/">U.S. FDA</a> Priority Review for TAR-200 in high-risk NMIBC 
Phase 2b SunRISe-1 study #AUA25 
✅82.4 % CR rate 
☑️ 52.9 % cancer-free at least one year after CR

jnj.com/media-center/p…
European Urology (@euplatinum) 's Twitter Profile Photo

🔬 New in @EUEuropeanUrol: The PUrE RCT 1 compares FURS vs. ESWL for lower pole kidney stones ≤10 mm. 🧑⚕️💰 A landmark trial on both clinical and cost effectiveness. #UroTwitter #Urolithiasis 1/ 📈 Findings from 461 randomized patients (48 UK centers): ✔️ Stone-free: FURS 72%

🔬 New in @EUEuropeanUrol: The PUrE RCT 1 compares FURS vs. ESWL for lower pole kidney stones ≤10 mm.
🧑⚕️💰 A landmark trial on both clinical and cost effectiveness.
#UroTwitter #Urolithiasis

1/
📈 Findings from 461 randomized patients (48 UK centers):
✔️ Stone-free: FURS 72%
European Urology (@euplatinum) 's Twitter Profile Photo

📢 New in European Urology: A meta-analysis of 43 studies (8,119 pts) confirms the diagnostic value of PSMA PET in prostate cancer BCR by Mazzone et al. 🔹 Positivity: 60% post-RP, 92% post-RT 🔹 48% positivity even at PSA 0.2–0.5 ng/ml 🔹 Site matters: pelvic nodes > bone >

📢 New in European Urology:
A meta-analysis of 43 studies (8,119 pts) confirms the diagnostic value of PSMA PET in prostate cancer BCR by Mazzone et al. 

🔹 Positivity: 60% post-RP, 92% post-RT
🔹 48% positivity even at PSA 0.2–0.5 ng/ml
🔹 Site matters: pelvic nodes &gt; bone &gt;